77 related articles for article (PubMed ID: 16570237)
1. Cardiovascular risk management by blocking the endocannabinoid system.
Bramlage P; Mühlen I; Randeva H; Spanswick D; Lehnert H
Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):75-81. PubMed ID: 16570237
[TBL] [Abstract][Full Text] [Related]
2. [Blocking the endocannabinoid system -- weight reduction and cardiovascular risk management].
Bramlage P; Böcking W; Kirch W
Dtsch Med Wochenschr; 2005 Mar; 130(12):665-8. PubMed ID: 15776349
[TBL] [Abstract][Full Text] [Related]
3. Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors.
Woods SC
Am J Med; 2007 Mar; 120(3 Suppl 1):S19-25. PubMed ID: 17320518
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system and the treatment of obesity.
Pagotto U; Vicennati V; Pasquali R
Ann Med; 2005; 37(4):270-5. PubMed ID: 16019725
[TBL] [Abstract][Full Text] [Related]
5. CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health.
Cota D
Diabetes Metab Res Rev; 2007 Oct; 23(7):507-17. PubMed ID: 17683024
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z; Valla V
Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
[TBL] [Abstract][Full Text] [Related]
7. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
Kunos G
Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite.
Cooper SJ
Eur J Pharmacol; 2004 Oct; 500(1-3):37-49. PubMed ID: 15464019
[TBL] [Abstract][Full Text] [Related]
9. The role of the endocannabinoid system in atherosclerosis.
Mach F; Steffens S
J Neuroendocrinol; 2008 May; 20 Suppl 1():53-7. PubMed ID: 18426500
[TBL] [Abstract][Full Text] [Related]
10. New approaches for the management of patients with multiple cardiometabolic risk factors.
Van Gaal LF; Peiffer F
J Endocrinol Invest; 2006; 29(3 Suppl):83-9. PubMed ID: 16751712
[TBL] [Abstract][Full Text] [Related]
11. Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors.
Jensen MD
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():143S-149S. PubMed ID: 16931496
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic options for modifying cardiometabolic risk factors.
Aronne LJ
Am J Med; 2007 Mar; 120(3 Suppl 1):S26-34. PubMed ID: 17320519
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid system in food intake and metabolic regulation.
Jesudason D; Wittert G
Curr Opin Lipidol; 2008 Aug; 19(4):344-8. PubMed ID: 18607180
[TBL] [Abstract][Full Text] [Related]
14. [The endocannabinoid system and the regulation of the metabolism].
Ducobu J
J Pharm Belg; 2005; 60(3):84-8. PubMed ID: 16252509
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases.
Bellocchio L; Mancini G; Vicennati V; Pasquali R; Pagotto U
Curr Opin Pharmacol; 2006 Dec; 6(6):586-91. PubMed ID: 17027338
[TBL] [Abstract][Full Text] [Related]
16. [The endocannabinoid system and the regulation of the metabolism].
Ducobu J
Rev Med Brux; 2005; 26(3):159-64. PubMed ID: 16038140
[TBL] [Abstract][Full Text] [Related]
17. Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: insulin and melanocortins.
Matias I; Vergoni AV; Petrosino S; Ottani A; Pocai A; Bertolini A; Di Marzo V
Neuropharmacology; 2008 Jan; 54(1):206-12. PubMed ID: 17675101
[TBL] [Abstract][Full Text] [Related]
18. At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction.
Montecucco F; Di Marzo V
Trends Pharmacol Sci; 2012 Jun; 33(6):331-40. PubMed ID: 22503477
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system: a promising target for the management of type 2 diabetes.
Scheen AJ
Curr Protein Pept Sci; 2009 Feb; 10(1):56-74. PubMed ID: 19275673
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid system and energy metabolism.
Bellocchio L; Cervino C; Pasquali R; Pagotto U
J Neuroendocrinol; 2008 Jun; 20(6):850-7. PubMed ID: 18601709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
